Lv1
30 积分 2022-11-25 加入
Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study
2个月前
已完结
Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial
3个月前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of SHR-2010, a novel anti-MASP-2 antibody, in healthy volunteers: a randomized, double-blind, placebo-controlled phase 1 study
3个月前
已完结
Diagnosis and classification of chronic prurigo
5个月前
已完结
The race to reset autoimmune diseases
6个月前
已完结
The potential of CD38 protein as a target for autoimmune diseases
6个月前
已完结
Anti‐CD19 chimeric antigen receptor T‐cell therapy in older patients with relapsed or refractory large B‐cell lymphoma: A multicenter study
6个月前
已完结
皖公网安备34019202002308
